insights_auto
Why is BJDX up 6.50%?
Dive Deeperchevron_right
BJDX:NASDAQ
Bluejay Diagnostics Inc
$0.81
arrow_upward
+6.50%(+0.049) 1D
$0.82
arrow_upward
+0.97% (+0.0079)todayPre-market
Closed: Oct 6, 4:00:00 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for BJDX...
Open
$0.78
High
$0.84
Low
$0.76
Mkt. cap
3.99M
Avg. vol.
2.34M
Volume
20.32K
52-wk high
$16.68
52-wk low
$0.76
EPS
-$49.45
Beta
0.89
Shares outstanding
4.47M
No. of employees
6
Open
$0.78
High
$0.84
Low
$0.76
Mkt. cap
3.99M
Avg. vol.
2.34M
Volume
20.32K
52-wk high
$16.68
52-wk low
$0.76
EPS
-$49.45
Beta
0.89
Shares outstanding
4.47M
No. of employees
6
News stories
From web sources and news partners
kalkine.ca
·
19 hours ago
What's Moving Biotech Stocks Pre-Market? Bluejay Diagnostics (NASDAQ:BJDX), Kairos Pharma (NYSE:KAPA), Rezolute (NASDAQ:RZLT) in Focus
TipRanks
·
19 hours ago
Bluejay Unveils SYMON-II Baseline Data for Symphony Test
Benzinga
·
20 hours ago
Bluejay Diagnostics Advances Rapid Biomarker Testing For Sepsis Patients
Stock Titan
·
22 hours ago
Among 777 patients with sepsis or septic shock, 140 did not survive 28 days in Bluejay's study.
About Bluejay Diagnostics Inc
CEO-
Employees6
Founded2015
HeadquartersActon, Massachusetts, United States
SectorMedical device
Websitebluejaydx.com